Literature DB >> 14145473

PRIMARY ALDOSTERONISM AND THE EFFECTS OF TWO MINERALOCORTICOID INHIBITORS--TRIAMTERENE AND SPIRONOLACTONE (ALDACTONE).

G L ROBERTSON, J W DAWSON.   

Abstract

Entities:  

Keywords:  ADENOMA; ADRENAL GLAND NEOPLASMS; DIURETICS; HYPERALDOSTERONISM; PATHOLOGY; PTERINS; SPIRONOLACTONE; SURGERY, OPERATIVE; TRIAMTERENE

Mesh:

Substances:

Year:  1964        PMID: 14145473      PMCID: PMC1922796     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  Triamterene, a new natruretic agent. Preliminary observations in man.

Authors:  A P CROSLEY; L M RONQUILLO; W H STRICKLAND; F ALEXANDER
Journal:  Ann Intern Med       Date:  1962-02       Impact factor: 25.391

2.  Aldosteronism and hypertension. Primary aldosteronism versus hypertensive disease with secondary aldosteronism.

Authors:  J W CONN
Journal:  Arch Intern Med       Date:  1961-06

3.  Use of an aldosterone antagonist in the diagnosis of primary hyperaldosteronism.

Authors:  H P HIGGINS; M O'SULLIVAN
Journal:  Can Med Assoc J       Date:  1960-12-17       Impact factor: 8.262

4.  Juxtaglomerular cell counts and human hypertension.

Authors:  C TURGEON; S C SOMMERS
Journal:  Am J Pathol       Date:  1961-02       Impact factor: 4.307

5.  Effects of a spirolactone (SC-8109) in primary mineralocorticoid excess.

Authors:  H KISTLER; T F FRAWLEY
Journal:  J Clin Endocrinol Metab       Date:  1960-08       Impact factor: 5.958

6.  Effect of an aldosterone antagonist on sodium and potassium excretion in primary hyperaldosteronism.

Authors:  R M SALASSA; V R MATTOX; M H POWER
Journal:  J Clin Endocrinol Metab       Date:  1958-07       Impact factor: 5.958

7.  Kaliopenic nephropathy.

Authors:  J W CONN; R D JOHNSON
Journal:  Am J Clin Nutr       Date:  1956 Sep-Oct       Impact factor: 7.045

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.